Coloplast A/S

COLO-B · Nasdaq Copenhagen · Healthcare

412.50DKK −0.7%last day

Price as of 2 October 2026

The price over the past year, with dividends: −21.8%

Performance

1 month

−11.1%

1 year

−21.8%

3 years, per year

−15.6%

5 years, per year

−15.1%

Largest fall, 3 years

−58.8%

Below the peak now

−60.0%

Volatility, 1 year

27.5%

Return with dividends reinvested.

Key figures

P/E

33.2

P/B

6.9

Dividend yield

5.6%

Return on equity

+20.7%

Net margin

+9.7%

Market value

14.0 bn USD

Quality, value and trend

Where Coloplast stands against every Nordic stock today. 100 is best.

Quality72

Profitability and a sound balance sheet over time. Better than 72% of Nordic stocks.

Value22

The price measured against earnings, assets and cash flow. Better than 22% of Nordic stocks.

Trend43

The price development over the past year. Better than 43% of Nordic stocks.

Combined39

Quality, value and trend together. Better than 39% of Nordic stocks.

About Coloplast

Coloplast A/S is a company in healthcare, listed on Nasdaq Copenhagen. The share trades in DKK. It has around 17,000 employees.

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis